Preventive Pharmacotherapy for Cardiovascular Disease: A Modelling Study Considering Health Gain, Costs, and Cost-Effectiveness when Stratifying by Absolute Risk

Cardiovascular disease (CVD) is the leading cause of death internationally. We aimed to model the impact of CVD preventive double therapy (a statin and anti-hypertensive) by clinician-assessed absolute risk level. An established and validated multi-state life-table model for the national New Zealand...

Descripción completa

Detalles Bibliográficos
Autores principales: Nghiem, Nhung, Knight, Josh, Mizdrak, Anja, Blakely, Tony, Wilson, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925295/
https://www.ncbi.nlm.nih.gov/pubmed/31862895
http://dx.doi.org/10.1038/s41598-019-55372-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925295/
https://www.ncbi.nlm.nih.gov/pubmed/31862895
http://dx.doi.org/10.1038/s41598-019-55372-8

Ejemplares similares